{"id":3523,"date":"2022-04-29T14:38:54","date_gmt":"2022-04-29T11:38:54","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=3523"},"modified":"2026-10-30T13:29:47","modified_gmt":"2026-10-30T11:29:47","slug":"iasis-pharma-participation-in-the-spring-days-of-edae-2022","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-spring-days-of-edae-2022\/","title":{"rendered":"IASIS PHARMA PARTICIPATION IN THE \u201cSPRING DAYS OF EDAE\u201d 2022"},"content":{"rendered":"<p><strong>MAKEDONIA PALACE, THESSALONIKI<br \/>\n15-17\/04\/2022<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the hybrid (both physical presence &amp; as a webinar) dermatological conference &#8220;Spring Days of EDAE&#8221;, which took place on April 15-17,2022 at &#8220;Makedonia Palace&#8221; Hotel, Thessaloniki. \u03a4his time, the conference program had a different orientation, with the emphasis put on Sexually Transmitted Diseases (STDs).<\/p>\n<p>At <strong>IASIS PHARMA<\/strong> exhibition stand, two dermatological products were exhibited:<\/p>\n<p><strong>Modiwart<\/strong>\u00ae<strong>\/Imiquimod<\/strong>, an innovative modifier of the immune response system, indicated for the treatment of: External Genital Warts, but also Superficial Basal Cell Carcinoma and Aktinic Ceratosis. <strong>Modiwart<\/strong>\u00ae comes in packages of 12 sachets. Each sachet contains 12,5mg imiquimod in 250mg of cream (5%).<\/p>\n<p><strong>Combi<\/strong><strong>\u00ae<\/strong>, a combination of fluprednidene + miconazole cream, for the treatment of Inflammatory Dermatomycoses such as Fungal Vaginitis (or Vaginal Candidiasis), but also in \u0395czema re-infected by fungi. <strong>Combi<\/strong><strong>\u00ae<\/strong> comes in tubes of 50 g. Each gram of the cream contains 1mg Fluprednidene acetate and 20mg Miconazole nitrate.<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-3520\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-225x300.jpg\" alt=\"photo-edae\" width=\"338\" height=\"450\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-120x160.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-200x267.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-225x300.jpg 225w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-400x533.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-500x666.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-600x800.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-700x933.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-768x1024.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae-800x1066.jpg 800w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/04\/photo-edae.jpg 908w\" sizes=\"(max-width: 338px) 100vw, 338px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MAKEDONIA PALACE, THESSALONIKI 15-17\/04\/2022 IASIS PHARMA participated in the hybrid (both physical presence &amp; as a webinar) dermatological conference &#8220;Spring Days of EDAE&#8221;, which took place on April 15-17,2022 at &#8220;Makedonia Palace&#8221; Hotel, Thessaloniki. \u03a4his time, the conference program had a different orientation, with the emphasis put on Sexually Transmitted Diseases (STDs). At IASIS PHARMA  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157],"tags":[],"class_list":["post-3523","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-UP","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=3523"}],"version-history":[{"count":5,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3523\/revisions"}],"predecessor-version":[{"id":3528,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3523\/revisions\/3528"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=3523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=3523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=3523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}